血清PIGU蛋白作为乳腺癌诊断生物标志物的鉴定
该研究通过生物信息学分析发现PIGU蛋白在乳腺癌组织中高表达且为预后风险因素,并用ELISA检测血清PIGU水平,发现乳腺癌患者血清PIGU显著高于健康人,与CEA弱正相关,与CA153和CA125无显著相关。
要点
- 乳腺癌组织PIGU表达高于正常组织,且为预后风险因素(HR>1,p<0.05)。
- 血清PIGU在乳腺癌患者中显著高表达(p<0.01),与CEA弱正相关(r=0.3270)。
- PIGU预测乳腺癌的AUC为0.8941,有潜力作为预后标志物。
核心结论
- PIGU有潜力成为乳腺癌的预测预后标志物。
研究设计与样本
- 采用生物信息学方法进行差异表达分析,用单因素生存分析和ROC曲线探讨血清PIGU与预后相关性,ELISA检测血清PIGU水平,电化学发光免疫法测定CEA、CA153和CA125。
主要发现
- 乳腺癌肿瘤组织中PIGU蛋白表达水平高于正常组织。
- PIGU表达水平是乳腺癌患者的预后风险因素(HR>1,p<0.05),且具有良好预测能力(AUC=0.8941)。
- 与健康个体相比,乳腺癌患者血清PIGU水平显著高表达(p<0.01)。
- 血清PIGU表达水平与CEA弱正相关(r=0.3270),与CA153和CA125无显著相关(p>0.05)。
临床怎么用
- 血清PIGU可能作为乳腺癌辅助诊断和预后评估的候选生物标志物,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Finding markers of breast cancer that are strong specificity and high. Sensitivity is important. The expression of phosphatidylinositol U(PIGU) protein is increased in a variety of tumor cells, but the role of its secreted fragment in breast cancer is lacking. METHODS: Differential expression analysis was performed in breast cancer patients by bioinformatics method. Univariate survival analysis and ROC curve plotting were used to explore the correlation between serum PIGU and the prognosis of breast cancer patients. ELISA was used to detect serum PIGU level. Electrochemiluminescence immunoassay was used to determine serum carcinoembryonic antigen (CEA), carbohydrate antigen-153(CA153) and carbohydrate antigen-125 (CA125) levels. RESULTS: The expression level of PIGU protein in breast cancer tumor tissues was higher than that in normal tissues, and PIGU expression level was a prognostic risk factor for breast cancer patients (HR > 1, p < 0.05) and had good predictive power (AUC = 0.8941). Compared with healthy individuals, the serum PIGU level of breast cancer patients was significantly highly expressed (p < 0.01), and the serum PIGU expression level was weakly positively correlated with CEA (r = 0.3270), but not significantly correlated with CA153 and CA125 (p > 0.05). CONCLUSION: PIGU has the potential to be a predictive prognostic marker for breast cancer.
引用
- An S, Liu F, Shi Y, et al. Identification of serum phosphatidylinositol glycan anchor biosynthesis class U protein as diagnostic biomarker for breast cancer. Clin Chim Acta. 2025. PMID: 39922250. doi:10.1016/j.cca.2025.120183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。